Navigation Links
Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?

Eli Lilly, the pharmaceutical company, is in a tight spot, defending its position against the law suits from mentally ill patients//, about the company’s best-selling schizophrenia drug, Zyprexa. The company is being blamed for undermining the health risks of the drug, which is being linked to obesity and high blood sugar.

On the basis of many supporting documents and internal communication between managers in the company, ample evidence has surfaced, that the company has indeed kept under wraps, the harmful side-effects of the drug Zyprexa.

Even the company’s published statistics which the sales representatives have been tutored to make light of, portrays statistics that about 30% of the patients consuming Zyprexa, have gained 22 pounds within a year of consuming the drug and some have gained as much as 100 pounds. The documents clearly portray the abiding worry of the company that its sales might plummet if they were honest about the drug’s effect on weight gain or blood sugar levels.

The company has not taken the allegation lightly and has completely denied it. Lilly explained that the FDA has been enabled with a clear picture of all the clinical trials and reviews regarding the usage of the drug world-wide. But documents in circulation within the company relates to an entirely different story. Apprehension regarding the drug’s side effects has been debated as early as 1999, to the extent that company bigwigs felt it could jeopardize the sales of their most popular product, if it were publicized.


AV
'"/>




Page: 1

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Eli Lilly Releases Digital Insulin Pen
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
5. Leeches Provide Clues Regarding The Prevention Of Heart Disease
6. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
7. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
8. Adolescents Influenced By Maternal Attitude Regarding Weight Control
9. Reforms Required With Regard To Mental Health Facilities
10. Tension between MP And the Cancer Council Head Regarding Screening Test for Male Cancer
11. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
Post Your Comments:
(Date:5/22/2013)... The Muscular Dystrophy Association scored a huge ... annual Charlotte Muscle Team event held May 21 by ... with muscle disease. , "The Charlotte community really ... families,” said MDA Divisional Director Theresa Miller. “From the ... "Buddy" to make their night extra special, to the ...
(Date:5/22/2013)... Amy Norton HealthDay Reporter , , WEDNESDAY, May ... with athlete,s foot knows there is something about feet ... the first detailed "map" of the fungal groups that ... feet are the hottest neighborhood. It,s no secret ... such as bacteria, viruses and fungi, both outside and ...
(Date:5/22/2013)... People in the United States have been taking water ... much of the world, water shortages are normal and baths ... warns against taking water for granted and provides ways to ... in the United States. , Sharon Kleyne is host of ... live or by podcast on World Talk Radio, Voice America, ...
(Date:5/22/2013)... ID (PRWEB) May 22, 2013 Bodybuilding.com ... This Memorial Day (May 27, 2013) Bodybuilding.com will be donating ... of the amount. , “We are extremely grateful for ... the Armed Forces,” said Ryan DeLuca, CEO and founder of ... heroes who have sacrificed so much. Hire Heroes USA is ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...
Breaking Medicine News(10 mins):Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9
... , , , ... diagnostic services for veterinarians and pet owners, announced today it has ... Company and ProScan Imaging, both headquartered in Cincinnati. Financial terms were ... in Vienna, Va., Raleigh, N.C. and San Francisco and is the ...
... , Paul A. Markowski to Join ACCP as ... Aug. 10 The American College of Chest Physicians announced today that ... new Executive Vice President and CEO for the international medical specialty society. ... and CEO in the society,s 75-year history. , , ...
... Conn., Aug. 10 VION PHARMACEUTICALS, INC. (OTC ... the Oncologic Drugs Advisory Committee (ODAC) Meeting at which its ... , , The ODAC reviews and ... investigational human drug products for use in the treatment of ...
... Indiana University,s Center for Health Policy and Professionalism Research ... for individuals under age 65 remains virtually the same ... involved the government would be. Many ... insurance option, such as that being proposed by President ...
... human cancer tumors, the Ras protein literally "drives cells crazy," ... Life Sciences at Tel Aviv University. Prof. Kloog was the ... against pancreatic cancer, currently in clinical trials. Now, new research ... Pharmacology shows that the drug might be able to slow ...
... The Fountain of Life Group was in Canton, Ohio this weekend ... Pro Football Hall of Fame Yearbook. Fountain of Life is excited ... support of the Hall,s flagship publication. VaNu is featured in the ... Roger Staubach. , , The Pro Football Hall ...
Cached Medicine News:Health News:AnimalScan, LLC Acquires Iams Pet Imaging, LLC 2Health News:American College of Chest Physicians Names New CEO 2Health News:Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM) 2Health News:Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM) 3Health News:Americans remain divided on government involvement in health insurance, IU survey shows 2Health News:Americans remain divided on government involvement in health insurance, IU survey shows 3Health News:Taking the needle's sting out of diabetes 2Health News:Fountain of Life Group Debuts VaNu at the Pro Football Hall of Fame Enshrinement Weekend 2
(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...
(Date:5/22/2013)... and TORONTO , May ... (OTCBB: GNBT) today announced three presentations demonstrating the superiority ... its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). ... of the American Society of Clinical Oncology (ASCO) to ... May 31 through June 4, 2013. The ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... reduced signs and symptoms of SLE,disease at ... activity at 76 weeks-, ROCKVILLE, Md., June ... today announced the presentation of Phase 2,trial ... activity across multiple clinical,measures, was well tolerated ...
... - Neurogen,Corporation (Nasdaq: NRGN) today announced that data ... for NG2-73, the Company's,lead compound for the treatment ... SLEEP 2007 Annual Meeting of the Associated,Professional Sleep ... studies with NG2-73 in chronic insomnia patients,are currently ...
Cached Medicine Technology:Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... Block and its operation software are ... of gene expression, genotyping, counting bacterial/viral ... microarray results. Exicycler is capable of ... such as protein-protein and protein-ligand, using ...
... easily converts any DNA Engine thermal cycler into ... with any of our user-changeable sample blocks. The ... it to keep pace with the evolving needs ... DNA Engine base units, new or existing. The ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Medicine Products: